LATAM Daily Brief
SEE OTHER BRANDS

Following the news from Latin America

LATAM Daily Brief: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on LATAM Daily Brief.

Press releases published on April 22, 2025

Midland annonce l’acquisition du projet aurifère Kan dans la Fosse du Labrador

Midland annonce l’acquisition du projet aurifère Kan dans la Fosse du Labrador

MONTRÉAL, 22 avr. 2025 (GLOBE NEWSWIRE) -- Exploration Midland inc. (« Midland ») (TSX-V : MD) a le plaisir d’annoncer l’acquisition de 100 % du projet d’or Kan que détenait une société privée (Les Ressources Tectonic inc. (« Ressources Tectonic »)). Le …

Midland Announces the Acquisition of the Kan Gold Project in the Labrador Trough

Midland Announces the Acquisition of the Kan Gold Project in the Labrador Trough

MONTREAL, April 22, 2025 (GLOBE NEWSWIRE) -- Midland Exploration Inc. (“Midland”) (TSX-V: MD) is pleased to announce the acquisition of 100% interest in the Kan gold project from a private company (Ressources Tectonic). The Kan project is located in the …

Emerita Intersects 10.8 Meters Grading 4.8% Copper, 1.4 g/t Gold and 8.9 Meters Grading 1.1% Copper, 1.2 g/t Gold at El Cura Deposit

Emerita Intersects 10.8 Meters Grading 4.8% Copper, 1.4 g/t Gold and 8.9 Meters Grading 1.1% Copper, 1.2 g/t Gold at El Cura Deposit

TORONTO, April 22, 2025 (GLOBE NEWSWIRE) --  Emerita Resources Corp. (TSX-V: EMO; OTCQB: EMOTF; FSE: LLJA) (the “Company” or “Emerita”) continues to intersect copper-gold mineralization with associated zinc-lead-silver at its ongoing drilling campaign at …

Rapport Therapeutics to Participate in Upcoming Investor Conferences

Rapport Therapeutics to Participate in Upcoming Investor Conferences

BOSTON and SAN DIEGO, April 22, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for …

Medicenna to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference

Medicenna to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference

TORONTO and HOUSTON, April 22, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines targeting cancer and autoimmune …

Lotus Technology Reports Unaudited Fourth Quarter and Full Year 2024 Financial Results

Lotus Technology Reports Unaudited Fourth Quarter and Full Year 2024 Financial Results

Over 12,000 vehicles delivered in 2024, a year-on-year increase over 70%. Total revenue reached $924 million, a 36% year-on-year growth. Achieved a reduction in operating expenses for five consecutive quarters through rigorous execution of efficiency …

Newcore Gold Drilling Intersects 2.50 g/t Gold over 15.0 Metres and 3.00 g/t Gold over 10.0 metres at the Enchi Gold Project, Ghana

Newcore Gold Drilling Intersects 2.50 g/t Gold over 15.0 Metres and 3.00 g/t Gold over 10.0 metres at the Enchi Gold Project, Ghana

VANCOUVER, British Columbia, April 22, 2025 (GLOBE NEWSWIRE) -- Newcore Gold Ltd. ("Newcore" or the "Company") (TSX-V: NCAU, OTCQX: NCAUF) is pleased to announce additional drill results from the 35,000-metre drill program underway at the Company’s 100% …

Athene Survey Finds Sandwich Generation’s Retirement Plans Affected by Intergenerational Caregiving

Athene Survey Finds Sandwich Generation’s Retirement Plans Affected by Intergenerational Caregiving

WEST DES MOINES, Iowa , April 22, 2025 (GLOBE NEWSWIRE) -- A new survey conducted by Athene of the Sandwich Generation, defined as people aged 40-59 who provide financial or caregiving support to both adult children and elderly relatives, found that nearly …

Lipella Reports Positive Phase 2a Results from Second LP-310 Cohort in Oral Lichen Planus; Final Data Expected Q2 2025

Lipella Reports Positive Phase 2a Results from Second LP-310 Cohort in Oral Lichen Planus; Final Data Expected Q2 2025

Second Cohort Results Highlight Efficacy Across All Key Measures and Reinforce Safety of Twice-Daily Oral Rinse Phase 2a Study Now Fully Enrolled Across All Three Dose Cohorts Advancing Toward Phase 2b IND Submission and Broader Regulatory Engagement …

Telix Reports US$186M Q1 Revenue, Up 62% YOY

Telix Reports US$186M Q1 Revenue, Up 62% YOY

MELBOURNE, Australia and INDIANAPOLIS, April 22, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today provides an update on its commercial and operational performance for the quarter ended 31 March 2025 ( …

Ekosystém Bitget v 1. čtvrtletí získal 20 milionů nových uživatelů a zaznamenal 159% nárůst spotového trhu na platformě

Ekosystém Bitget v 1. čtvrtletí získal 20 milionů nových uživatelů a zaznamenal 159% nárůst spotového trhu na platformě

VICTORIA, Seychely, April 22, 2025 (GLOBE NEWSWIRE) -- Bitget, přední kryptoměnová burza a společnost zaměřená na Web3, zakončila první čtvrtletí roku 2025 s celkovým objemem obchodů ve výši 2,08 bilionu USD, a to díky prudkému, 159% nárůstu spotových …

Sirona Biochem Secures Strategic Investment Agreements and New Joint Venture with Promura GmbH

Sirona Biochem Secures Strategic Investment Agreements and New Joint Venture with Promura GmbH

VANCOUVER, British Columbia, April 22, 2025 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona”), a biotechnology company specializing cosmetic ingredients and new drug discoveries, is pleased to announce the successful …

Integral Metals Welcomes Shervin Pishevar as an Advisor to the Company

Integral Metals Welcomes Shervin Pishevar as an Advisor to the Company

CALGARY, Alberta, April 22, 2025 (GLOBE NEWSWIRE) -- Integral Metals Corp. (CSE: INTG | OTC: ITGLF | FSE: ZK9) (the “Company” or “Integral”) is pleased to announce the addition of Shervin Pishevar as an Advisor to the Company. With his extensive experience …

HUTCHMED Completes Patient Enrollment of a Phase II Registration Study of Savolitinib in Gastric Cancer in China

HUTCHMED Completes Patient Enrollment of a Phase II Registration Study of Savolitinib in Gastric Cancer in China

HONG KONG and FLORHAM PARK, N.J., April 22, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that it has completed enrollment of the registration phase of its Phase II trial of savolitinib in  …

Scorpius Holdings Receives NYSE American Notice of Delisting and Reports Plans to Appeal

Scorpius Holdings Receives NYSE American Notice of Delisting and Reports Plans to Appeal

San Antonio, TX, April 21, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization (“CDMO”), today reported that it received notice from the NYSE …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service